Category: Oncology/Hematology
Global Oncology/Hematology
-
HPV Testing and Pap Test Market: By Product Type (HPV test, Pap test and Co-test); By Application (Cervical cancer and Vaginal cancer); By Distribution Channel (Hospitals and clinics, Diagnostic centers and Others), And Region – Global Analysis of Market Size, Share & Trends For 2021–2022 And Forecasts To 2032
... Global Analysis of Market Size, Share & Trends For 2021–2022 And Forecasts To 2032 HPV Testing and Pap Test Market: By Product Type (HPV test, Pap test and Co-test); By Application (Cervical cancer and Vaginal ... Read More
-
Pancreatic Cancer Drugs Global Market Opportunities And Strategies To 2032
... information they need to assess the global Pancreatic cancer drugs market as it emerges from the COVID 19 shut down. Reasons to Purchase Gain a truly global perspective with the most comprehensive report available on ... Read More
-
Oncology Drugs Global Market Opportunities And Strategies To 2032
... need to assess the global oncology drugs market as it emerges from the COVID-19 shut down. Reasons to Purchase Gain a truly global perspective with the most comprehensive report available on this market covering 50 ... Read More
-
Global Dendritic Cell Cancer Vaccine Market Size study & Forecast, by Products Outlook (CreaVax, Sipuleucel-T and others), By End-use (Pediatrics, Adults) and Regional Analysis, 2022-2029
... USD 236.6 million in 2021 and is anticipated to grow with a healthy growth rate of more than 12.18% over the forecast period 2022-2029. Dendritic cells (DCs) are an uncommon class of leukocytes. Due to ... Read More
-
AI In Oncology Market Size, Share & Trends Analysis Report By Component (Software Solutions, Hardware, Services), By Cancer Type, By Treatment Type, By Region, And Segment Forecasts, 2023 - 2030
... & Trends The global AI in oncology market size is expected to reach USD 9.58 billion by 2030 and expand at a CAGR of 34.6% from 2023 to 2030, according to a new report by ... Read More
-
Global Acute Myeloid Leukemia Biomarker Detection Market Growth 2023-2029
... to grow at a CAGR of % from 2023 to 2029. United States market for Acute Myeloid Leukemia Biomarker Detection is estimated to increase from US$ million in 2022 to US$ million by 2029, at ... Read More
-
Next Generation Sequencing Market - By Product (Instruments, Consumables, Services), By Application (Research, Clinical {Cardiovascular, Reproductive Health, Cancer, Infectious Diseases}), By Type (Whole Genome Sequencing, Exome Sequencing, Targeted Sequencing), By Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing), By End-use (Hospitals & Clinics, Pharmaceutical & Biotechnology Companies) & Forecast, 2023 - 2032
... Semiconductor Sequencing), By End-use (Hospitals & Clinics, Pharmaceutical & Biotechnology Companies) & Forecast, 2023 - 2032 Next-generation sequencing (NGS) market is set to witness substantial growth through 2032 owing to the increasing use of the ... Read More
-
Global Non-Hodgkin's Lymphoma Treatment Market Report and Forecast 2023-2031
... at a CAGR of 9.10% during the forecast period of 2023-2031 to reach a value of USD 18.18 billion by 2031. The market growth can be attributed to the increasing incidence of Non-Hodgkin's lymphoma and ... Read More
-
2023 Global: Circulating Tumor Cells (Ctcs) And Cancer Stem Cells (Cscs) Market - Innovative Markets Forecast (2029) report
... (2029) report analyzies the market size, projected growth/decline and regional data for the period 2018 through 2029. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project ... Read More
-
2023 Global: Cancer Immunotherapy Drug Discovery Outsourcing - Innovative Markets Forecast (2029) report
... data for the period 2018 through 2029. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2018 ... Read More
-
Global Acute Myeloid Leukemia Treatment Market Report and Forecast 2023-2031
... of 11.4% during the forecast period of 2023-2031. The increasing prevalence of AML and the development of new therapies are the primary drivers of market growth. Acute Myeloid Leukemia Treatment Market: Introduction Acute myeloid Leukemia ... Read More
-
Global Acute Myeloid Leukemia Biomarker Detection Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
... valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were ... Read More
-
Global Acute Myeloid Leukemia Biomarker Detection Supply, Demand and Key Producers, 2023-2029
... % CAGR during the forecast period (2023-2029). Acute myeloid leukemia is a malignant neoplastic disease that usually results from the deterioration of stem cells in the bone marrow. Biomarker detection is a method that can ... Read More
-
Lymphoma Therapeutics Market By Disease Type (Hodgkin Lymphoma, Non-Hodgkin Lymphoma), By Treatment Type (Immune Therapy, Chemotherapy, Targeted Therapy, Radiation Therapy), By Route of Administration (Oral Route, Injectable), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies): Global Opportunity Analysis and Industry Forecast, 2023-2032
... Pharmacies): Global Opportunity Analysis and Industry Forecast, 2023-2032 The Lymphoma Therapeutics Market is valued for $15,691.45 million in 2022 and is estimated to reach $35,207.45 million by 2032, exhibiting a CAGR of 8.4% from 2023 ... Read More
-
Cancer Pain Management Market, Size, Global Forecast 2023-2030, Industry Trends, Growth, Share, Outlook, Impact of Inflation, Opportunity Company Analysis
... to Renub Research. Pain is a common and dreaded symptom experienced by individuals undergoing cancer treatment and long-term cancer survivors. Cancer pain can result from the disease itself, its treatments, or a combination of both ... Read More
-
Multiple Myeloma Market, Size, Global Forecast 2023-2030, Industry Trends, Growth, Share, Outlook, Impact of Inflation, Opportunity Company Analysis
... to Renub Research. Multiple myeloma, or Kahler's disease, is a cancer that impacts plasma cells, white blood cells that generate antibodies to combat infections. The condition results in an accumulation of abnormal plasma cells in ... Read More
-
Cancer Vaccine Market by Technology (Dendritic Cells, Recombinant Vaccines, Antigen/Adjuvant Vaccines, Whole Cell Vaccines, and Viral & DNA Vaccines), Type Preventive Vaccines and Therapeutic Vaccines), Disease Indication (Cervical Cancer, Prostate Cancer, and Others), and End User (Pediatrics and Adults): Global Opportunity Analysis and Industry Forecast, 2023–2030.
... User (Pediatrics and Adults): Global Opportunity Analysis and Industry Forecast, 2023–2030. The cancer vaccine market size was valued at USD 5.75 billion in 2022, and is predicted to reach USD 13.4 billion by 2030, with ... Read More
-
Global Nasogastric Tube Market Size study & Forecast, by Patient Type (Adult, Pediatric, Geriatric), By Indication (Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia, Others), By Type (Small-bore feeding tubes, Large-bore feeding tubes), By End-use (Hospitals & Nursing Homes, Home Care) and Regional Analysis, 2022-2029
... End-use (Hospitals & Nursing Homes, Home Care) and Regional Analysis, 2022-2029 Global Nasogastric Tube Market is valued at approximately USD 479.7 million in 2021 and is anticipated to grow with a healthy growth rate of ... Read More
-
Cell Analysis Market By Product (Consumables, Services, Instruments, Software), By Technique (Flow cytometry, Mass Spectrometry, Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Others), By Application (Oncology, Immunology, Cardiology, Genetic Disease, Stem Cells, Others), By End User (Biotechnology and Pharmaceutical Companies, Hospitals and Diagnostic Laboratories, Academic and Research Laboratories, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032
... End User (Biotechnology and Pharmaceutical Companies, Hospitals and Diagnostic Laboratories, Academic and Research Laboratories, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032 The Cell Analysis Market was valued at $17.1 billion in 2022 and is ... Read More
-
Cancer Gene Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028
... at lower cost coupled with increasing aesthetic consciousness among the population significantly increases the demand for cancer gene therapy across different parts of the globe. Besides, growing awareness about the advantages of using gene therapy ... Read More
-
Gastric Cancer Market By Disease Type (Adenocarcinoma, Lymphoma, Gastrointestinal Stromal Tumor, Carcinoid Tumor, Others), By Treatment Type (Immunotherapy, Targeted Therapy, Chemotherapy, Radiation Therapy and Surgery), By Drug Class Outlook (PD-1/PD-L1 Inhibitors, HER2 Antagonists, VEGFR2 Antagonists, Others), By Route of Administration (Oral, Injectable), By Distribution Channel (Hospital Pharmacies, Specialty and Retail Pharmacies, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031
... Others), By Route of Administration (Oral, Injectable), By Distribution Channel (Hospital Pharmacies, Specialty and Retail Pharmacies, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031 The global gastric cancer market is anticipated to reach $10.7 billion ... Read More
-
Global Hemato Oncology Testing Market - 2023-2030
... by 2030. The market is growing at a CAGR of 4.8% during the forecast period (2023-2030). Hematologic oncology integrates two fields of medicine: hematology, the study of the blood, and oncology, the study of cancer. ... Read More
-
Radiopharmaceutical Theranostics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type [Alpha Emitters, Beta Emitters, and Positron Emission Tomography (PET) Tracers], Radioisotope [Technetium-99, Gallium-68, Iodine-131, Iodine-123, 18F, Y-90, Lutetium (Lu) 177, Copper (Cu) 67, Copper (Cu) 64, and Others], Source (Nuclear Reactors and Cyclotrons), Application [Targeted Therapeutic (Rx) and Companion Diagnostic (DX)], Indication (Oncology, Cardiology, Neurology, and Others), and End User (Hospitals, Diagnostic Imaging Centers, Academic and Research Institutes, and Others)
... Copper (Cu) 67, Copper (Cu) 64, and Others], Source (Nuclear Reactors and Cyclotrons), Application [Targeted Therapeutic (Rx) and Companion Diagnostic (DX)], Indication (Oncology, Cardiology, Neurology, and Others), and End User (Hospitals, Diagnostic Imaging Centers, Academic ... Read More
-
Global Bladder Cancer Market 2022-2028
... past harmful radiation experiences, parasitic infections, and certain changes in the genes that are linked to bladder cancer. Past treatment with radiation therapy or certain anticancer drugs, such as cyclophosphamide or ifosfamide cause bladder cancer, ... Read More
-
Global Colorectal Cancer Diagnosis and Therapeutics Market 2022-2028
... cancer therapeutics is a malignancy that begins in the colon or the rectum, and can likewise be named, colon tumors or rectal cancer depending upon where they begin. The rising prevalence of colorectal cancer due ... Read More
Research Assistance
